-39.2%
PINS vs MRNA
+221.0%
-260.2%
-65.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -3.4% | +3.6% | +0.3% |
| 7D | +1.0% | -12.1% | +13.1% | +1.6% |
| 30D | -12.0% | -1.3% | -10.7% | -12.1% |
| 3M | -17.9% | +250.9% | -268.8% | -25.4% |
| 6M | -1.0% | +343.0% | -344.1% | -13.6% |
| YTD | -26.0% | +657.4% | -683.5% | -41.1% |
| 1Y | -28.5% | +794.9% | -823.4% | -44.7% |
| 3Y | -39.2% | +218.1% | -257.3% | -48.5% |
| All | -39.2% | +221.0% | -260.2% | -48.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling